Baillie Gifford & CO Insulet Corp Transaction History
Baillie Gifford & CO
- $128 Billion
- Q2 2025
A detailed history of Baillie Gifford & CO transactions in Insulet Corp stock. As of the latest transaction made, Baillie Gifford & CO holds 2,135,068 shares of PODD stock, worth $727 Million. This represents 0.53% of its overall portfolio holdings.
Number of Shares
2,135,068
Previous 2,250,755
5.14%
Holding current value
$727 Million
Previous $591 Million
13.49%
% of portfolio
0.53%
Previous 0.53%
Shares
7 transactions
Others Institutions Holding PODD
# of Institutions
888Shares Held
62.8MCall Options Held
300KPut Options Held
625K-
Vanguard Group Inc Valley Forge, PA8.71MShares$2.96 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$2.06 Billion0.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.74MShares$1.61 Billion0.31% of portfolio
-
State Street Corp Boston, MA3.06MShares$1.04 Billion0.04% of portfolio
-
Geode Capital Management, LLC Boston, MA1.93MShares$656 Million0.04% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $23.6B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...